Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo | Nature Communications
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis | Semantic Scholar
Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes | Gene Therapy
Peptide sequences and molecular structures of FDA approved GLP-1 RAs. | Download Scientific Diagram
Figure 1.3 from Cardiovascular Effects and Mechanism(s) of Action of Glucagon-Like Peptide-1 Metabolite, GLP-1(28-36) | Semantic Scholar
Liraglutide, a once-daily human GLP-1 analogue | Semantic Scholar
Frontiers | GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH
The incretin hormone GLP‐1 and mechanisms underlying its secretion - Tian - 2016 - Journal of Diabetes - Wiley Online Library
Molecular interaction between GLP-1 and GLP1R. The amino acid sequences... | Download Scientific Diagram
Amino acid sequence of GLP-1 (a) and exenatide (b). | Download Scientific Diagram
Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes | ACS Medicinal Chemistry Letters
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes | Pharmacological Reviews
Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking - Chemical Science (RSC Publishing) DOI:10.1039/C9SC02079A
GLP-1R | SpringerLink
Amino acid sequence of active GLP-1 showing multiple sites of cleavage... | Download Scientific Diagram
Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications | Journal of Medicinal Chemistry
GLP-1 & GLP-2
Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications | Journal of Medicinal Chemistry
Amino acid sequence of glucagon like peptide-1 (GLP-1) and GLP-1... | Download Scientific Diagram
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease | Scientific Reports
